Dernières nouvelles pour Core & Main (NYSE:CNM) Stock

CORE & MAIN INC-CLASS A

Core & Main

Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is principally generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.

Core & Main Inc

Conmed Corp

CHINA MERCHANTS SECS ADR by China Merchants Securities Co.,Ltd

China Merchants Securities Asset Management Co.,Ltd

Canadian Metals Inc

CANADIAN METALS INC by Canadian Metals Inc.

CANOE MINING VENTURES by Canoe Mining Ventures Corp.

Canoe Mining Ventures Corp

Canamex Gold Corp

WIIM

GE Vernova shares are trading higher after Susquehanna initiated its coverage on the stock with a Positive rating and announced a price target of $370.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs cut Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) price target from $83 to $60. Goldman Sachs analyst Catherine O&#8217;Brien maintained a Buy rating. Delta Air shares closed at $42.42 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/DAL/analyst-ratings">view this stock</a>.</li>
<li>Morgan Stanley slashed the price target for PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) from $95 to $86. Morgan Stanley analyst Kimberly Greenberger maintained an Equal-Weight rating. PVH shares closed at $76.43 on Tuesday. See how other <a href="https://www.benzinga.com/quote/PVH/analyst-ratings">analysts view this stock.</a></li>
<li>Truist Securities raised GFL Environmental Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFL#NYSE">GFL</a>) price target from $54 to $58. Truist Securities analyst Tobey Sommer maintained a Buy rating. GFL Environmental shares closed at $47.77 on Tuesday. <a href="https://www.benzinga.com/quote/GFL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James cut the price target for nCino, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) from $42 to $32. Raymond James analyst Alexander Sklar maintained an Outperform rating. nCino shares closed at $28.12 on Tuesday. <a href="https://www.benzinga.com/quote/NCNO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Benchmark cut the price target for Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) from $41 to $33. Benchmark analyst Mark Palmer maintained a Buy rating. Hut 8 shares closed at $13.32 on Tuesday. See how other analysts vi<a href="https://www.benzinga.com/quote/HUT/analyst-ratings">ew this stock</a>.</li>
<li>UBS cut Union Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) price target from $255 to $245. UBS analyst Thomas Wadewitz maintained a Neutral rating. Union Pacific shares settled at $237.17 on Tuesday. <a href="https://www.benzinga.com/quote/UNP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo cut Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) price target from $9 to $7. Wells Fargo analyst Chris Carey maintained an Equal-Weight rating. Newell Brands shares closed at $6.18 on Tuesday. <a href="https://www.benzinga.com/quote/NWL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc slashed AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) price target from $83 to $80. Keybanc analyst Michael Leshock maintained an Overweight rating. AAR shares closed at $55.37 on Tuesday.  <a href="https://www.benzinga.com/quote/AIR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James raised the price target for Southwest Airlines Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) from $40 to $42. Raymond James analyst Savanthi Syth maintained an Outperform rating. Southwest shares settled at $31.59 on Tuesday. <a href="https://www.benzinga.com/quote/LUV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup increased The Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) price target from $85 to $102. Citigroup analyst Christopher Allen upgraded the stock from Neutral to Buy. Charles Schwab shares closed at $77.67 on Tuesday. <a href="https://www.benzinga.com/quote/SCHW/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying LUV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="579" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02130748/image-27-1024x579.png" alt="" class="wp-image-853806" style="width:492px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02130748/image-27-1024x579.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02130748/image-27-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02130748/image-27-768x434.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02130748/image-27.png 1118w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44605585/how-to-earn-500-a-month-from-conagra-brands-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Conagra Brands Stock Ahead Of Q3 Earnings</a> </li>
</ul>
Image via Shutterstock

Price Target

Intraday Update

Analyst Ratings

NCNO

SCHW

Southwest Airlines To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Wednesday

Trading Ideas

TOPW

Top Win Shares Halted On A Circuit Breaker To The Upside: Stock At The High Of The Day $13.20

Revvity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Wednesday.</a>
The company announced today that the U.S. Food and Drug Administration has approved its Auto-Pure 2400 liquid handling platform, integrated with the T-SPOT.TB test <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44604507/revvity-secures-fda-approval-for-improved-automated-latent-tuberculosis-test" rel="noreferrer noopener">for latent tuberculosis detection</a>.
First launched outside the U.S. in 2024, this combination is now available to improve laboratory productivity while maintaining superior clinical performance in TB testing.
The integration of the Auto-Pure 2400 system with the T-SPOT.TB test provides a high-throughput solution for laboratories, allowing them to process latent TB tests at a higher volume without compromising clinical accuracy.
The system can test up to 24 samples per run, completing Day 1 testing in under 3.5 hours with minimal user interaction.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44608617/jp-morgan-hikes-us-recession-odds-to-40-tariffs-create-a-dilemma-for-the-fed" rel="noreferrer noopener">JPMorgan Hikes Recession Odds As Tariffs Create &#8216;A Dilemma For The Fed&#8217;</a>
This efficiency is crucial in enhancing diagnostic speed and supporting timely TB treatment and containment.
The T-SPOT.TB test, recognized by the WHO as the only ELISPOT-based interferon-gamma release assay, ensures reproducible results with fewer indeterminate outcomes, making it especially reliable for immunocompromised patients.
Yves Dubaquie, senior VP of diagnostics at Revvity, highlighted that automating the process enables better patient outcomes through increased throughput and enhanced reliability.
&#8220;By automating&nbsp;T-SPOT.TB&nbsp;testing, we are empowering laboratories with increased throughput and reliability, ultimately leading to better patient outcomes,&#8221; Dubaquie added.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, RVTY stock has gained over 4% in the past year. Investors can gain exposure to the stock via T. Rowe Price Capital Appreciation Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCAF#NYSE">TCAF</a>).
Price Action: RVTY shares are trading higher by 2.48% to $106.90 at last check Wednesday.
Read now:
<ul>
<li><a href="https://www.benzinga.com/25/04/44589523/trumps-liberation-day-tariff-plan-could-ignite-global-trade-shakeup-betting-markets-price-in-the-pain" target="_blank" rel="noreferrer noopener">Trump Tariffs Could Ignite Global Trade Shakeup: Betting Markets Price In Pain</a></li>
</ul>
Image via Shutterstock.

Equities

News

Markets

Movers

General

RVTY

TCAF

What's Going On With Revvity Stock Today?

Goldman Sachs analyst Will Nance maintains Toast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) with a Neutral and lowers the price target from $43 to $38.

TOST

Goldman Sachs Maintains Neutral on Toast, Lowers Price Target to $38

Goldman Sachs analyst Joe Ritchie maintains Timken (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKR#NYSE">TKR</a>) with a Neutral and lowers the price target from $85 to $75.

Goldman Sachs Maintains Neutral on Timken, Lowers Price Target to $75

<h3>Gainers</h3>
<ul>
<li>ConnectM Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) stock rose 66.7% to $0.83 during Wednesday's regular session. The market value of their outstanding shares is at $24.0 million. </li>
<li>TTEC Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEC#NASDAQ">TTEC</a>) shares moved upwards by 58.56% to $5.18. The company's market cap stands at $247.6 million. </li>
<li>Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) stock rose 18.38% to $1.83. The market value of their outstanding shares is at $594.3 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares moved upwards by 15.58% to $5.34. The market value of their outstanding shares is at $3.5 million. </li>
<li>Palladyne AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) shares rose 12.22% to $6.52. The company's market cap stands at $229.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) shares fell 95.4% to $0.37 during Wednesday's regular session. The company's market cap stands at $35.3 million. </li>
<li>BingEx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLX#NASDAQ">FLX</a>) stock decreased by 52.17% to $2.5. The company's market cap stands at $177.2 million. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares fell 14.02% to $2.27. The market value of their outstanding shares is at $33.8 million. </li>
<li>Sunrise New Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPOW#NASDAQ">EPOW</a>) shares decreased by 10.68% to $0.92. The company's market cap stands at $24.0 million. </li>
<li>Huachen AI Parking Mgmt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAI#NASDAQ">HCAI</a>) shares decreased by 9.26% to $7.45. The market value of their outstanding shares is at $236.3 million. </li>
<li>OneConstruction Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEG#NASDAQ">ONEG</a>) shares declined by 8.58% to $2.24. The market value of their outstanding shares is at $29.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

CNTM

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

HCAI

MVST

ONEG

PDYN

TTEC

ZCAR

11 Industrials Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Sportsman's Warehouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWH#NASDAQ">SPWH</a>) stock rose 97.9% to $1.91 during Wednesday's regular session. The market value of their outstanding shares is at $72.4 million. The company's, Q4 earnings came out yesterday. </li>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) stock moved upwards by 34.58% to $0.02. The company's market cap stands at $2.5 million. </li>
<li>Genius Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) stock rose 20.74% to $0.26. The market value of their outstanding shares is at $20.2 million. </li>
<li>Autozi Internet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) stock moved upwards by 16.5% to $0.93. The company's market cap stands at $98.5 million. </li>
<li>Yoshiharu Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YOSH#NASDAQ">YOSH</a>) shares increased by 16.4% to $17.1. The company's market cap stands at $29.5 million. As per the press release, Q4 earnings came out today. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) shares moved upwards by 15.03% to $3.4. The company's market cap stands at $938.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jiuzi Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) shares fell 25.7% to $2.84 during Wednesday's regular session. The company's market cap stands at $31.2 million. </li>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCTM#NASDAQ">TCTM</a>) shares declined by 10.16% to $0.4. The company's market cap stands at $4.0 million. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) stock decreased by 9.78% to $0.91. The market value of their outstanding shares is at $1.3 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
<li>Kaival Brands Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) shares fell 9.55% to $0.55. The market value of their outstanding shares is at $6.3 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) shares fell 9.44% to $0.4. The market value of their outstanding shares is at $4.6 million. </li>
<li>Aureus Greenway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGH#NASDAQ">AGH</a>) stock fell 9.1% to $0.6. The company's market cap stands at $8.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JZXN

KAVL

SPHL

SPWH

TCTM

TRNR

WOOF

YOSH

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Allakos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLK#NASDAQ">ALLK</a>) stock rose 48.2% to $0.32 during Wednesday's regular session. The company's market cap stands at $29.0 million. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) shares moved upwards by 43.52% to $3.1. The market value of their outstanding shares is at $4.9 million. </li>
<li>Genprex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNPX#NASDAQ">GNPX</a>) shares rose 43.37% to $0.33. The company's market cap stands at $2.8 million. </li>
<li>Scilex Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCLX#NASDAQ">SCLX</a>) shares rose 33.97% to $0.32. The company's market cap stands at $58.3 million. </li>
<li>Sunshine Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) stock moved upwards by 30.52% to $2.71. The market value of their outstanding shares is at $7.3 million. </li>
<li>Alumis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMS#NASDAQ">ALMS</a>) shares increased by 29.62% to $9.38. The market value of their outstanding shares is at $510.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) stock fell 67.3% to $0.52 during Wednesday's regular session. The company's market cap stands at $1.7 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) stock declined by 35.72% to $0.17. The market value of their outstanding shares is at $2.0 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) shares declined by 28.42% to $0.59. The market value of their outstanding shares is at $6.7 million. </li>
<li>Edgewise Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) shares decreased by 24.05% to $15.29. The company's market cap stands at $1.4 billion. </li>
<li>NeOnc Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTHI#NASDAQ">NTHI</a>) stock fell 23.89% to $8.57. The market value of their outstanding shares is at $193.3 million. </li>
<li>Processa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) stock declined by 22.31% to $0.32. The market value of their outstanding shares is at $1.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALLK

ALMS

EWTX

GNPX

NTHI

PCSA

RSLS

SBFM

SCLX

SYRA

TCRT

12 Health Care Stocks Moving In Wednesday's Intraday Session

Goldman Sachs analyst Brian Lee maintains Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) with a Neutral and lowers the price target from $1 to $0.5.

NOVA

Goldman Sachs Maintains Neutral on Sunnova Energy Intl, Lowers Price Target to $0.5

<h3>Gainers</h3>
<ul>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock increased by 75.4% to $0.05 during Wednesday's regular session. </li>
<li>AstroNova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALOT#NASDAQ">ALOT</a>) shares rose 22.64% to $10.94. The market value of their outstanding shares is at $82.3 million. </li>
<li>Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) shares moved upwards by 16.24% to $27.33. The company's market cap stands at $362.3 million. </li>
<li>Red Cat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) shares increased by 15.64% to $7.39. The company's market cap stands at $632.7 million. As per the news, the Q3 earnings report came out 2 days ago. </li>
<li>Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) stock moved upwards by 13.45% to $7.22. The company's market cap stands at $50.0 million. </li>
<li>Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares increased by 13.39% to $8.86. The market value of their outstanding shares is at $2.5 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) stock declined by 21.7% to $22.03 during Wednesday's regular session. The company's market cap stands at $2.5 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Trident Digital Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) stock decreased by 19.63% to $0.24. The market value of their outstanding shares is at $15.4 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares declined by 18.54% to $18.41. The company's market cap stands at $183.6 million. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) stock declined by 11.13% to $2.39. The company's market cap stands at $5.6 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) stock decreased by 10.08% to $0.57. The market value of their outstanding shares is at $6.0 million. The company's, Q4 earnings came out yesterday. </li>
<li>Sagtec Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGT#NASDAQ">SAGT</a>) stock decreased by 9.34% to $2.33. The company's market cap stands at $29.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

ALAR

ALOT

DGLY

MLGO

RCAT

RGTI

SAGT

SLNH

TDTH

12 Information Technology Stocks Moving In Wednesday's Intraday Session

RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) will release its fourth-quarter financial results, after the <a href="https://www.benzinga.com/quote/rh/earnings">closing bell, on Wednesday, April 2</a>.
Analysts expect the Corte Madera, California-based company to report quarterly earnings at $1.92 per share, up from 72 cents per share in the year-ago period. RH projects quarterly revenue of $829.56 million, compared to $738.26 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 12, RH reported third-quarter revenue of $811.73 million, missing the consensus estimate of $812.16 million.
RH shares rose 2% to close at $239.06 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/RH/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Wedbush analyst Seth Basham maintained an Outperform rating and slashed the price target from $500 to $350 on March 26, 2025. This analyst has an accuracy rate of 67%.</li>
<li>UBS analyst Michael Lasser maintained a Neutral rating and cut the price target from $440 to $250 on March 21, 2025. This analyst has an accuracy rate of 77%.</li>
<li>Wells Fargo analyst Zachary Fadem maintained an Overweight rating and lowered the price target from $500 to $375 on March 18, 2025. This analyst has an accuracy rate of 84%.</li>
<li>Goldman Sachs analyst Kate McShane upgraded the stock from Sell to Neutral and boosted the price target from $261 to $374 on Jan. 30, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Morgan Stanley analyst Simeon Gutman upgraded the stock from Equal-Weight to Overweight and increased the price target from $435 to $530 on Jan. 13, 2025. This analyst has an accuracy rate of 66%.</li>
</ul>
Considering buying RH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02031635/image-16-1024x594.png" alt="" class="wp-image-852623" style="width:566px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02031635/image-16-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02031635/image-16-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02031635/image-16-768x445.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02031635/image-16.png 1095w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44584246/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Earnings

RH Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Goldman Sachs analyst Will Nance maintains Remitly Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) with a Buy and lowers the price target from $33 to $26.

RELY

Goldman Sachs Maintains Buy on Remitly Global, Lowers Price Target to $26

<a href="https://x.com/PressSec/status/1907476290438901863" title="https://x.com/PressSec/status/1907476290438901863">https://x.com/PressSec/status/1907476290438901863</a>

Government

TSLA

White House Press Secretary Karoline Leavitt On X Posts "This "scoop" is garbage. Elon Musk and President Trump have both *publicly* stated that Elon will depart from public service as a special government employee when his incredible work at DOGE is complete."

Goldman Sachs analyst Joe Ritchie maintains Regal Rexnord (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRX#NYSE">RRX</a>) with a Buy and lowers the price target from $183 to $163.

Goldman Sachs Maintains Buy on Regal Rexnord, Lowers Price Target to $163

AMZN

GILD

GOOG

GOOGL

KLAC

CNBC Halftime Report Final Trades: Gilead Sciences, Amazon, Alphabet, KLA

<a href="http://www.benzinga.com/markets/cryptocurrency/25/03/44492055/fidelity-gears-up-to-launch-us-dollar-backed-stablecoin">Fidelity Investments</a> has introduced a new crypto-focused retirement account, giving individual investors the opportunity to hold digital assets directly in tax-advantaged retirement portfolios.
The <a href="https://www.fidelity.com/crypto/retirement-ira">offering</a> includes access to Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) and Litecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>), and is available to U.S. residents aged 18 and older.
Assets purchased through the new product are stored securely in cold wallets under Fidelity's custody. 
Investors can choose from traditional IRAs, Roth IRAs, or rollover options, with no fees attached to the crypto IRA service, according to the firm's official website.
The move comes as financial advisors increasingly embrace digital assets as part of diversified retirement strategies. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44607188/arthur-hayes-predicts-bitcoin-to-hit-250000-by-end-of-year">Arthur Hayes Predicts Bitcoin To Hit $250,000 By End Of Year</a>
A recent TMX VettaFi <a href="https://www.coindesk.com/business/2025/04/02/fidelity-lets-investors-directly-invest-in-crypto-through-new-retirement-plan">survey</a> found that more than half of advisors (57%) intend to grow their exposure to crypto-related exchange-traded funds, with a strong emphasis on crypto equity products.
"Fidelity is dedicated to delivering investment choices that align with evolving customer preferences," a company representative said, emphasizing the importance of providing education and guidance alongside new products.
Sources close to the development indicated that demand among Fidelity's clients for a secure, tax-efficient method to invest in crypto has been steadily rising.
Fidelity has long been active in the digital asset space, offering a suite of crypto-themed ETFs that allow investors to track asset prices indirectly. 
The firm recently filed paperwork to list a Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) ETF on the Cboe (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) exchange, expanding its presence in the crypto ETF market.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44605174/circles-revenue-grows-but-ipo-filing-shows-falling-profitability">Circle&#8217;s Revenue Grows, But IPO Filing Shows Falling Profitability</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$LTC

$SOL

CBOE

Fidelity Launches Fee-Free Crypto IRA, Offering Direct Access To Bitcoin, Ethereum, And Litecoin For US Investors

Goldman Sachs analyst James Yaro maintains Perella Weinberg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWP#NASDAQ">PWP</a>) with a Sell and lowers the price target from $20 to $18.

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

Goldman Sachs Maintains Sell on Perella Weinberg, Lowers Price Target to $18

Goldman Sachs analyst Will Nance maintains Payoneer Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYO#NASDAQ">PAYO</a>) with a Buy and lowers the price target from $11 to $9.

PAYO

Goldman Sachs Maintains Buy on Payoneer Global, Lowers Price Target to $9

Over the last few months, fears of a recession have hit truly high levels, with consumers and corporate CFOs getting ready for a recession. In the latest <a href="https://www.cnbc.com/2025/03/25/recession-is-coming-pessimistic-corporate-cfos-say-cnbc-survey.html">CNBC CFO Council survey</a>, conducted from March 10 to March 21, 75% of CFOs described themselves as &#8220;somewhat pessimistic&#8221; about the U.S. economy, and this dramatically differs from attitudes toward the end of 2024. Additionally, consumer confidence has fallen to 12-year lows as worries about the stability of their incomes, jobs, and businesses increase.
Despite a positive outlook for their own industries, most CFOs cannot say the same about the overall economic outlook. For the first time in the survey&#8217;s history, CFOs gave &#8220;Don&#8217;t know&#8221; as the answer to which stock market sector had the &#8220;best growth potential.&#8221;
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
There are many factors behind this growing pessimism, with U.S. trade policy being the main external business risk cited by 30% of the respondents. Inflation remains a concern, even though it has decreased over the past few years from 8% to 2.8%, which is still above the Federal Reserve&#8217;s 2% target. Reduced consumer demand ranks as the second and third most common concern among CFOs, cited by 25% and 20% of them respectively. As one CFO described the situation: &#8220;complete chaos, without an endgame strategy.&#8221;
Even with those challenges, the majority of CFOs think that if a recession does happen, it will in all likelihood be mild or moderate. But many remain divided about the economy&#8217;s longer-term trend, with 90% agreeing the Dow Jones Industrial Average will retest 40,000 before testing 50,000 again.
Trending: <a href="https://www.benzinga.com/money/arrived-private-credit-fund">Bezos' Favorite Real Estate Platform Launches A Way To Ride The Ongoing Private Credit Boom</a>
The Ripple Effect on Bitcoin and Crypto Markets
Historically, Bitcoin (and the overall crypto markets) tends to trade higher when the average participant is more willing to take on risk.
Bitcoin has been heavily correlated with the S&amp;P 500 over the last few years as it has gained more institutional adoption.&nbsp;
For example, both the equities market and Bitcoin experienced significant downturns during major events: in 2020 during COVID-19, in late 2021 and 2022 during the inflation crisis, and recently amidst recession fears. Currently, the S&amp;P 500 is down roughly 7.5% from its highs, while Bitcoin is down 20% from its all-time highs.
Economic Slow Down Effect
When it comes to a recession, one of the main drivers is consumers not spending money, or in other words, not exchanging their cash for goods and services.
The velocity of M2 money stock tracks the flow of money within the economy. While the overall trend has been downward since the late 1990s, there have been periods of rebounds—for example, during COVID in 2020. The printing of money and stimulus checks to citizens increased the number of transactions.
See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
Recently, this activity has started to slow down, which is why there have been many recession-related headlines and discussions.
While Bitcoin has had strong catalysts in recent times, such as ETF approval, institutional backing, countries adopting it as a currency of exchange, and the U.S. recently establishing a Bitcoin reserve—these catalysts can often be mere noise in the short to mid-term if liquidity is not flowing into the markets.
What to Watch: Key Indicators for Bitcoin and Equities in the Coming Weeks
To keep it simple, the two most important data points to watch in the next few weeks are how equities hold up against recession fears, as discussed. If equities continue to fall, historically, as shown, Bitcoin tends to follow risk-on markets, so we can expect that to play out again.
However, if equities hold up or consolidate in the next few weeks, that could potentially give Bitcoin the room to move back up toward ATHs, as it has the catalysts mentioned before.
Next, you should be watching global liquidity flows. You can find this metric on TradingView by using the following tickers: WALCL and M2V. These metrics track the Fed's balance sheet and M2 velocity.
Read Next:
<ul>
<li>Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
As long as the Fed's balance sheet remains in a Quantitative Tightening stance, Bitcoin and other risk-on markets will likely face pressure as they attempt to trade higher.
Once this metric reverses, we can expect a potential strong rally—but that is not the case currently. While a QT environment makes it harder for risk-on assets to trade higher, it does not mean they CANNOT trade higher.
Main Takeaway
As the markets navigate through uncertain times, patience is key. Given the current data, the likelihood of massive gains in stocks and other risk-on assets in the short to mid-term appears low. While conditions may change, it's important to remain cautious and wait for clearer signals before expecting significant upside.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/arrived-centennial">Jeff Bezos-Backed Arrived Homes Hits A Big Sale On Charlotte Property – Investors Earning A 34.7% Return</a></li>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
</ul>

Personal Finance

Recession Fears Surge: What Consumers and CFOs Expect – How It Could Impact Bitcoin and the Crypto Market

Comments

Core & Main

Actualités

Dernières nouvelles pour Core & Main (NYSE:CNM) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL